Clinical Trial Update: Study of the Gut Hormone Analogue Y14 in Adult Subjects [Phase 1]

View source ↗

Summary

Imperial College London’s Phase 1 study of the gut hormone analogue Y14 in adults with diabetes mellitus and obesity has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Obesity

Drugs mentioned

• Y14

Snippet

Sponsor: Imperial College London | Conditions: Diabetes Mellitus, Obesity | Phase 1 | Status: COMPLETED | Results posted: 2025-03-18